- Home
- IPHA vs CXDO Comparison
IPHA vs CXDO Comparison
Compare IPHA & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- CXDO
- Stock Information
- Founded
- IPHA 1999
- CXDO 1995
- Country
- IPHA France
- CXDO United States
- Employees
- IPHA N/A
- CXDO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- CXDO Telecommunications Equipment
- Sector
- IPHA Health Care
- CXDO Telecommunications
- Exchange
- IPHA Nasdaq
- CXDO Nasdaq
- Market Cap
- IPHA 160.1M
- CXDO 160.4M
- IPO Year
- IPHA 2019
- CXDO 1998
- Fundamental
- Price
- IPHA $2.24
- CXDO $6.90
- Analyst Decision
- IPHA Strong Buy
- CXDO Strong Buy
- Analyst Count
- IPHA 1
- CXDO 3
- Target Price
- IPHA $11.50
- CXDO $6.67
- AVG Volume (30 Days)
- IPHA 650.0K
- CXDO 165.2K
- Earning Date
- IPHA 03-20-2025
- CXDO 03-04-2025
- Dividend Yield
- IPHA N/A
- CXDO N/A
- EPS Growth
- IPHA N/A
- CXDO N/A
- EPS
- IPHA N/A
- CXDO 0.05
- Revenue
- IPHA $36,202,722.00
- CXDO $58,762,000.00
- Revenue This Year
- IPHA N/A
- CXDO $15.59
- Revenue Next Year
- IPHA $93.37
- CXDO $10.49
- P/E Ratio
- IPHA N/A
- CXDO $148.41
- Revenue Growth
- IPHA N/A
- CXDO 16.41
- 52 Week Low
- IPHA $1.29
- CXDO $2.92
- 52 Week High
- IPHA $3.51
- CXDO $7.07
- Technical
- Relative Strength Index (RSI)
- IPHA 63.01
- CXDO 73.91
- Support Level
- IPHA $2.07
- CXDO $6.01
- Resistance Level
- IPHA $2.38
- CXDO $7.07
- Average True Range (ATR)
- IPHA 0.13
- CXDO 0.28
- MACD
- IPHA 0.04
- CXDO 0.09
- Stochastic Oscillator
- IPHA 78.79
- CXDO 89.11
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.